The New Mexico House Health & Human Services Committee has approved legislation that would legalize medical psilocybin, advancing the bill to the full House for consideration.
The committee voted 8 to 1 today in favor of Senate Bill 219, the Medical Psilocybin Act. The measure previously cleared the Senate with a 33 to 4 vote after gaining approval from multiple Senate committees, including Finance, Judiciary, and Tax, Business and Transportation. If the bill is passed by the House, it will be sent to Governor Michelle Lujan Grisham for consideration.
If enacted, the legislation would allow individuals with specific behavioral health conditions—such as major treatment-resistant depression, PTSD, substance use disorders, and end-of-life distress—to receive psilocybin-assisted treatment. It would also create an advisory board, a treatment equity fund, and a research fund while removing psilocybin from the state’s Controlled Substances Act to protect patients, clinicians, and producers.
The program would be implemented by Dec. 31, 2027.
“When we’re facing epidemic levels of depression, anxiety, PTSD, and other debilitating mental health conditions, we owe it to those suffering to explore promising new treatments like psilocybin,” said State Representative Elizabeth Thomson (D), who is sponsoring a companion bill in the House. “By establishing a highly regulated, state-run program, we can provide alternative options to those not responding to traditional treatment, in a safe, controlled environment.”
